Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may increase the risk of pulmonary aspiration among patients undergoing surgery ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
In a study published in Cell, a research team led by Zhu Shujia from the Center for Excellence in Brain Science and ...
We developed a robotic joint with an agonist–antagonist muscle pair structure that can easily change its mechanical impedance using a position-controlled motor combined with a grommet, which changes ...
These drugs are known as GLP-1 agonists. GLP-1 is a naturally occurring hormone that works with your brain to control digestion. Drugs like Wegovy agonize the GLP-1 receptors all throughout your body, ...
When you first enter a new world, you can either spawn near a structure or find one while exploring any of the three dimensions. While finding some can be quite easy, others are extremely hard to ...
“In terms of the list of conditions and/ or symptoms that are reported to be increased by GLP1 receptor agonists, as expected gastrointestinal upset of various kinds is most common adverse effect. The ...
Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...
Summary: A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback